Global Longlife Hospital and Research Limited (BOM:543520)
India · Delayed Price · Currency is INR 10.11
-0.39 (-3.71%)
At close: Jun 17, 2026
BOM:543520 Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | -17.2 | 1.99 | -21.88 | 18.28 | 35.74 |
Depreciation & Amortization | - | 4.81 | 12.49 | 11.67 | 11.43 |
Other Amortization | - | 0.01 | 0.02 | - | 0 |
Loss (Gain) From Sale of Assets | - | -43.12 | 0.58 | - | 0.61 |
Loss (Gain) From Sale of Investments | - | -5.71 | - | - | - |
Other Operating Activities | -3.89 | 11.19 | -350.61 | 4.6 | 44.88 |
Change in Accounts Receivable | 0.92 | 16.25 | 77.51 | -7.9 | -10.66 |
Change in Inventory | - | 4.37 | 3.78 | 0.67 | -0.71 |
Change in Accounts Payable | - | -25.59 | 12.48 | -29.68 | 10.16 |
Change in Other Net Operating Assets | -24.94 | 159.01 | 214.91 | -401.79 | 2.79 |
Operating Cash Flow | -45.1 | 123.21 | -50.72 | -404.15 | 94.25 |
Operating Cash Flow Growth | - | - | - | - | 37.06% |
Capital Expenditures | - | -0.72 | -10.49 | -20.04 | -4.75 |
Sale of Property, Plant & Equipment | - | 211.72 | 0.22 | - | 0.17 |
Investment in Securities | 0.3 | 5.68 | 1.5 | -0.18 | 2.68 |
Other Investing Activities | 0.05 | 1.31 | 0.6 | 1.22 | 2.04 |
Investing Cash Flow | 0.35 | 217.99 | -8.18 | -19.01 | 0.13 |
Short-Term Debt Issued | - | - | 38.96 | - | 13.37 |
Long-Term Debt Issued | - | - | - | 8.21 | - |
Total Debt Issued | - | - | 38.96 | 8.21 | 13.37 |
Short-Term Debt Repaid | - | -93.27 | -2.21 | -2.21 | - |
Long-Term Debt Repaid | -0 | -34.1 | -2.33 | - | -96.85 |
Total Debt Repaid | -0 | -127.37 | -4.54 | -2.21 | -96.85 |
Net Debt Issued (Repaid) | -0 | -127.37 | 34.42 | 6 | -83.48 |
Issuance of Common Stock | - | - | - | 455 | - |
Other Financing Activities | - | -2.76 | -7.68 | -4.01 | -13.11 |
Financing Cash Flow | -0 | -130.13 | 26.74 | 456.99 | -96.59 |
Miscellaneous Cash Flow Adjustments | - | - | -0 | 0 | - |
Net Cash Flow | -44.75 | 211.07 | -32.16 | 33.83 | -2.22 |
Free Cash Flow | -45.1 | 122.48 | -61.21 | -424.2 | 89.49 |
Free Cash Flow Growth | - | - | - | - | 30.95% |
Free Cash Flow Margin | - | 2111.78% | -45.28% | -180.47% | 27.25% |
Free Cash Flow Per Share | -4.30 | 11.66 | -5.83 | -41.66 | 12.79 |
Cash Interest Paid | - | 2.76 | 7.68 | 4.01 | 13.11 |
Cash Income Tax Paid | 5.03 | 2.64 | 0.97 | 12.7 | -6.69 |
Levered Free Cash Flow | -28.39 | -32.15 | 259.56 | -237.13 | 62.71 |
Unlevered Free Cash Flow | -28.39 | -30.32 | 263.96 | -235.13 | 72.14 |
Change in Working Capital | -24.01 | 154.04 | 308.68 | -438.7 | 1.58 |